It is important to note that while tesofensine may have potential in increasing energy levels, human clinical tests specifically targeting energy enhancement are limited
In trials, Wegovy and Saxenda reduced body weight by around 15% and around 5%, respectively
Early detection and understanding the causes can lead to effective treatment and lifestyle changes
Status: Research phase No completed human RCTs Not FDA-approved SC injection or oral (research only) Caveat: BPC-157 is under review at the FDA's July 2026 peptide advisory panel and is currently restricted for compounding
The most common side effects of Zepbound are: nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching/gas, hair loss, and heartburn